ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
13
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,205
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Efficacy of ixekizumab therapy: Integrated analysis of 3 double-blind, controlled trials
Publication date
Created:
May 2016
Publication date
(Print):
May 2016
Journal:
Journal of the American Academy of Dermatology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Efficacy of Communicating Science
Author and article information
Journal
Title:
Journal of the American Academy of Dermatology
Abbreviated Title:
Journal of the American Academy of Dermatology
Publisher:
Elsevier BV
ISSN (Print):
01909622
Publication date Created:
May 2016
Publication date (Print):
May 2016
Volume
: 74
Issue
: 5
Page
: AB53
Article
DOI:
10.1016/j.jaad.2016.02.210
SO-VID:
1eab1cb4-2d2b-450a-858d-a50309fa9daf
Copyright ©
© 2016
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,205
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Authors:
Beatriz Joven
,
Raquel Hernández Sánchez
,
Eva Pérez-Pampín
…
Improvements in psoriasis within different body regions vary over time following treatment with ixekizumab.
Authors:
Andrew Blauvelt
,
Talia M Muram
,
Kyoungah See
…
Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis
Authors:
Akimichi Morita
,
Yukari Okubo
,
Yoji Morisaki
…
See all similar